# Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

> **NCT01444586** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2293 (actual)

## Conditions studied

- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee

## Interventions

- **DRUG:** Rivaroxaban (Xarelto, BAY59-7939)

## Key facts

- **NCT ID:** NCT01444586
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-08
- **Final completion:** 2014-07
- **Target enrollment:** 2293 (ACTUAL)
- **Last updated:** 2017-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444586, "Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01444586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*